Pular para o conteúdo
Merck

Clinical practice: Adult attention deficit-hyperactivity disorder.

The New England journal of medicine (2013-11-15)
Nora D Volkow, James M Swanson
RESUMO

Short-term trials involving adults with ADHD have shown significant improvements in symptoms with stimulants and atomoxetine; however, data on long-term benefits and risks of these medications, particularly among older persons, have been insufficient.